Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States
Value Health. 2014 Nov;17(7):A621-2.
doi: 10.1016/j.jval.2014.08.2203.
Epub 2014 Oct 26.